Diabetes Medication Recalls
Recalls of metformin and other drugs used to control blood sugar - metformin extended-release was recalled over the same nitrosamine impurity as valsartan.
160 recalls in this category, newest first.
Class II · Moderate risk Ongoing Jun 12, 2026
Reason CGMP Deviations: An incorrect detergent was used and the required swab sampling was not performed on a production hopper that had previously been…
Class II · Moderate risk Ongoing Mar 13, 2025
Reason CGMP Deviations
Class II · Moderate risk Ongoing Feb 25, 2025
Reason Presence of Foreign Tablets/Capsules.
Class II · Moderate risk Terminated Dec 30, 2024
Reason Presence of Foreign Tablets/Capsules: A Paracetamol 500 mg tablet was found in a 1000-count bottle of Metformin HCL ER Tablets USP, 500 mg.
Class II · Moderate risk Terminated Dec 17, 2024
Reason Failed Dissolution Specifications:
Class II · Moderate risk Completed Mar 12, 2024
Reason CGMP Deviations
Class III · Low risk Ongoing Jan 18, 2024
Reason Misprint on tablet
Class III · Low risk Ongoing Jan 18, 2024
Reason Misprint on tablet
Class II · Moderate risk Ongoing Apr 11, 2023
Reason Lack of Assurance of Sterility: Malformed crimped collar seal
Class II · Moderate risk Terminated Apr 6, 2023
Reason CGMP deviations.
Class II · Moderate risk Ongoing Mar 23, 2023
Reason cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
Class II · Moderate risk Ongoing Mar 23, 2023
Reason cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
Class II · Moderate risk Terminated Mar 20, 2023
Reason cGMP Deviations
Class II · Moderate risk Terminated Mar 17, 2023
Reason CGMP Deviations: recalling drug products following an FDA inspection.
Class II · Moderate risk Terminated Mar 17, 2023
Reason CGMP Deviations: recalling drug products following an FDA inspection.
Class II · Moderate risk Terminated Mar 17, 2023
Reason CGMP Deviations: recalling drug products following an FDA inspection.
Class II · Moderate risk Ongoing Mar 16, 2023
Reason CGMP Deviations
Class II · Moderate risk Ongoing Mar 16, 2023
Reason CGMP Deviations
Class II · Moderate risk Terminated Mar 13, 2023
Reason cGMP deviations
Class II · Moderate risk Terminated Mar 13, 2023
Reason cGMP deviations
Class II · Moderate risk Terminated Mar 13, 2023
Reason cGMP deviations
Class II · Moderate risk Terminated Mar 9, 2023
Reason Labeling: Label Mix-up
Class II · Moderate risk Terminated Feb 22, 2023
Reason CGMP Deviations: Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.
Class II · Moderate risk Terminated Feb 7, 2023
Reason CGMP Deviations: recalling drug products following an FDA inspection.
Class II · Moderate risk Terminated Feb 7, 2023
Reason CGMP Deviations: recalling drug products following an FDA inspection.